» Articles » PMID: 23628987

Kv3.1-containing K(+) Channels Are Reduced in Untreated Schizophrenia and Normalized with Antipsychotic Drugs

Overview
Journal Mol Psychiatry
Date 2013 May 1
PMID 23628987
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronal firing is a fundamental element of cerebral function; and, voltage-gated potassium (K(+)) channels regulate that firing through the repolarization of action potentials. Kv3-type channels (Kv3.1-Kv3.4) represent a family of voltage-gated K(+) channels that have fast-spiking properties. Kv3.1 channel subunits are predominantly localized to cortical parvalbumin (PV)-positive, inhibitory interneurons. The firing properties of these interneurons participate in establishing the normal gamma oscillations and synchrony of cortical neuronal populations, thought to be the signature of higher information processing in human brain. Schizophrenia (SZ) is associated with abnormalities in cortical gamma synchrony and in information processing, particularly with dysfunction in working memory and executive function. Here, we report the distribution of Kv3.1b and Kv3.2 protein in normal human brain, showing that Kv3.1b is limited to neocortical areas, whereas Kv3.2 is abundantly represented in neo- and subcortical regions. In SZ cases, levels of Kv3.1b protein are decreased in the neocortex, but only in cases without antipsychotic drug (APD) treatment; Kv3.1 levels are normal in antipsychotic-treated cases. Kv3.2 is not different in distribution or in level between normal and SZ cases, nor influenced by APD, in any region tested. The apparent increase in Kv3.1b protein levels by APDs in SZ neocortex was confirmed in laboratory rodents treated with chronic APDs. These findings show a decrease in Kv3.1b channel protein in SZ neocortex, a deficit that is restored by APDs. This alteration could be fundamentally involved in the cortical manifestations of SZ and in the therapeutic response to APDs.

Citing Articles

Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis.

Dybowski F, Scott D, Tamminga C Neuropsychopharmacology. 2025; .

PMID: 40016366 DOI: 10.1038/s41386-025-02077-4.


Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review.

Gee A, Dazzan P, Grace A, Modinos G Transl Psychiatry. 2025; 15(1):21.

PMID: 39856031 PMC: 11760974. DOI: 10.1038/s41398-024-03221-2.


Voltage-gated potassium channels as a potential therapeutic target for the treatment of neurological and psychiatric disorders.

Faulkner I, Pajak R, Harte M, Glazier J, Hager R Front Cell Neurosci. 2024; 18:1449151.

PMID: 39411003 PMC: 11473391. DOI: 10.3389/fncel.2024.1449151.


Dysfunctional Parvalbumin Neurons in Schizophrenia and the Pathway to the Clinical Application of Kv3 Channel Modulators.

Yanagi M, Hashimoto M Int J Mol Sci. 2024; 25(16).

PMID: 39201380 PMC: 11354421. DOI: 10.3390/ijms25168696.


Developmental dynamics of the prefrontal cortical SST and PV interneuron networks: Insights from the monkey highlight human-specific features.

Fin N, Yip A, Teo L, Homman-Ludiye J, Bourne J bioRxiv. 2024; .

PMID: 39026896 PMC: 11257587. DOI: 10.1101/2024.07.10.602904.


References
1.
Lodge D, Behrens M, Grace A . A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009; 29(8):2344-54. PMC: 2754752. DOI: 10.1523/JNEUROSCI.5419-08.2009. View

2.
Amann L, Gandal M, Halene T, Ehrlichman R, White S, McCarren H . Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull. 2010; 83(3-4):147-61. DOI: 10.1016/j.brainresbull.2010.04.008. View

3.
Uhlhaas P, Singer W . Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010; 11(2):100-13. DOI: 10.1038/nrn2774. View

4.
Porcello D, Ho C, Joho R, Huguenard J . Resilient RTN fast spiking in Kv3.1 null mice suggests redundancy in the action potential repolarization mechanism. J Neurophysiol. 2002; 87(3):1303-10. DOI: 10.1152/jn.00556.2001. View

5.
Cho R, Konecky R, Carter C . Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A. 2006; 103(52):19878-83. PMC: 1750867. DOI: 10.1073/pnas.0609440103. View